Research dossier
Clinical research on Molybdenum
2 trials reviewed across 2 indications.
Strongest evidence
General health
Mechanism
Molybdenum is the metal center of four human enzymes, most importantly sulfite oxidase, which detoxifies sulfite to sulfate during sulfur amino acid metabolism.
The biochemistry is real. The clinical relevance for a healthy adult is not. Dietary intake from legumes, grains, nuts, and organ meat reliably exceeds requirements. There are no trials showing supplemental molybdenum produces a health benefit in non-deficient adults.
Universally adequate from diet. The only clinical deficiency case described is in long-term parenteral nutrition without trace-element supplementation, which modern formulations have eliminated.
Trials cited
Molybdenum cofactor and human enzymology
positive · Systematic review
Mendel & Kruse, 2012, Biochimica et Biophysica Acta (review)Molybdenum is required for four human enzymes: sulfite oxidase, xanthine oxidase, aldehyde oxidase, and mitochondrial amidoxime-reducing component. Sulfite oxidase is the biologically critical one — without it, sulfur metabolism fails and severe neurological disease results. Inherited molybdenum cofactor deficiency is a serious metabolic disorder, but it is genetic, not dietary.
Mechanistic and inherited-disorder evidence. Says nothing about whether dietary or supplemental molybdenum confers benefit in healthy adults.
Cellular and detoxification function
Mechanism
Sulfite oxidase converts sulfite to sulfate. Xanthine oxidase processes purines toward uric acid. Aldehyde oxidase metabolizes aldehydes and several xenobiotics.
Marketing copy positions molybdenum as a 'detox' nutrient on the back of these enzyme roles. The mechanism is real but the clinical-trial gap is total — no human trial in healthy adults has shown that supra-dietary molybdenum improves any measurable detoxification, sulfite tolerance, or health outcome.
Cofactor adequacy is a dietary question, not a supplementation question. There is no mechanism by which extra molybdenum exceeds enzyme saturation in a beneficial way.
Molybdenum cofactor and human enzymology
positive · Systematic review
Mendel & Kruse, 2012, Biochimica et Biophysica Acta (review)Molybdenum is required for four human enzymes: sulfite oxidase, xanthine oxidase, aldehyde oxidase, and mitochondrial amidoxime-reducing component. Sulfite oxidase is the biologically critical one — without it, sulfur metabolism fails and severe neurological disease results. Inherited molybdenum cofactor deficiency is a serious metabolic disorder, but it is genetic, not dietary.
Mechanistic and inherited-disorder evidence. Says nothing about whether dietary or supplemental molybdenum confers benefit in healthy adults.
2 forms of Molybdenum compared
Sodium molybdate
Well absorbed (around 90%)
Best forThe form used in TPN repletion and most retail supplementsCheap, water-soluble, reliable absorption. The form-quality story for molybdenum is not consequential since the underlying clinical case for supplementation is weak.
Molybdenum glycinate (chelate)
Well absorbed
Best forMarketed as a 'gentle' or chelated form in multivitaminsNo clinical advantage over sodium molybdate has been demonstrated. The chelate label is marketing differentiation.
Are you deficient? Symptoms, risk groups, lab tests
Acquired dietary molybdenum deficiency in healthy adults has not been documented. The only described cases are long-term TPN patients before trace-element supplementation became standard.
Common symptoms
- Tachycardia (in severe acquired deficiency)
- Headache
- Night blindness
- Mental disturbances at the extreme
- Biochemical disruption of sulfur amino acid metabolism (xanthine, sulfite, sulfate handling)
Who is at risk
Long-term parenteral nutrition patients
Historical risk before TPN trace-element supplementation became standard. Modern TPN formulations include molybdenum and largely eliminate this scenario.
Patients with inherited molybdenum cofactor deficiency
A genetic disorder of cofactor synthesis, not a dietary deficiency. Presents in infancy with severe neurological features. Requires specialist metabolic care, not over-the-counter supplements.
Lab markers
Serum molybdenum
Rarely measured outside research settings; not part of routine clinical workup. Sulfite-oxidase activity and urinary sulfite/sulfate ratios are more functionally relevant when deficiency is suspected.
Better:Urinary sulfite, Urinary xanthine and hypoxanthine, Urinary sulfate-to-sulfite ratio
Side effects and drug interactions
Side effects
Gout-like joint symptoms (high-intake epidemiology only)
Uncommon · Reported with chronic intakes well above the UL of 2,000 mcg/day
Older Soviet-era epidemiology described joint complaints in workers exposed to high environmental molybdenum. Causal interpretation is contested and the exposures involved were far above any retail supplement dose.
Mild GI upset
Uncommon
Possible at high supplemental doses, generally not problematic at the trace amounts used in multivitamins.
Drug interactions
Other
No clinically significant drug interactions are well established at typical supplemental doses.
Routine clinical review is not required for the trace amounts present in multivitamins.
Other critical caveats
- Molybdenum supplementation has no demonstrated benefit in healthy adults. The RDA of 45 mcg/day is comfortably exceeded by ordinary dietary patterns.
- Inherited molybdenum cofactor deficiency is a severe genetic disorder, not a dietary one — it cannot be addressed by retail supplements and requires specialist metabolic care.
- Multivitamins commonly include molybdenum at trace doses. This is harmless but adds essentially nothing of value.
Frequently asked
Do I need to take molybdenum?
Almost certainly not. The RDA is 45 mcg/day for adults — a tiny amount that is met by legumes, whole grains, nuts, and organ meats. Acquired deficiency in healthy people is not documented. The only described cases were on outdated parenteral nutrition formulas without trace minerals.Does molybdenum help with detox or sulfite sensitivity?
Sulfite oxidase, the molybdenum-dependent enzyme, does process sulfites. But there is no clinical trial showing that supra-dietary molybdenum reduces sulfite reactions, headaches, or any 'detox' endpoint in healthy adults. The marketing claims outpace the data.What is the upper limit?
The Tolerable Upper Intake Level for adults is 2,000 mcg/day. Typical multivitamin doses sit at 50–75 mcg, well within range. Standalone high-dose products are unnecessary and unsupported.Why is molybdenum in my multivitamin then?
Because formulators include the full set of essential trace minerals to be comprehensive. At typical doses it is harmless, but it does not add meaningful clinical benefit on top of a normal diet.
References
- 01NIH Office of Dietary Supplements — Molybdenum Health Professional Fact Sheet
- 02StatPearls — Molybdenum Deficiency (NCBI Bookshelf)
Last reviewed2026-05-07